Why do North American businesses favour the UK?
The UK has become one of the most attractive, structured, and scalable markets for digital health globally, especially for firms seeking predictable reimbursement, strong institutional partners, and rapid adoption pathways.
The NHS (National Health Service) is a single, centralised buyer, with huge scale. There is active investment in digital transformation through modernisation of patient records (EPRs) and AI integration – plus the market is mature, receptive and high-yield.
Why is Asia gaining ground?
Asia is good for digital health businesses because it offers huge population scale, rapid digital adoption, strong government funding, and a high need for remote and AI-enabled care. The population is ageing rapidly, governments are investing and markets are receptive to foreign innovation. These are all conditions that favour international entrants with mature products, despite regulatory complexity.
What drives investment into Europe?
Businesses in Italy and Spain see growth opportunities everywhere, helped by EU-wide moves from local pilots to pan-European digital health infrastructure. Interoperability reforms, AI adoption, new cross-border data frameworks and a fast-growing innovation network linking major cities and health systems are giving companies shared access to hospitals, payers and validation centres that can test and scale technologies across Europe13.
M&A appetite cooling
Fewer than a fifth (18%) of digital health businesses globally are prioritising M&A (mergers and acquisitions) in the next 12 months as a route to expansion, likely reflecting economic and geopolitical risk rather than lack of strategic intent.
By 2030, digital health and wellness is expected to become increasingly personalised, proactive and connected, powered by AI, data analytics, wearable technologies and remote care14. However, achieving this vision will require:
- Scalable, interoperable and user-centric technology
- Stronger partnerships across healthcare and wellness ecosystems
- Investment focused on high-impact, outcome-driven innovation
- Robust governance, cybersecurity and risk management
- Greater emphasis on regulatory compliance and evidence-based outcomes
- Improved accessibility and health equity
Ultimately, success will depend not only on innovation, but on organisations' ability to build trust, demonstrate value and scale sustainably.